Related Articles
Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report
PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma
Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways
Bevacizumab treatment for newly diagnosed glioblastoma: Systematic review and meta-analysis of clinical trials
Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide